Global brokerages bullish on ALL, Astral Poly & DRL; here's why

ET Bureau|
Morgan Stanley on Ashok Leyland
1/6

Morgan Stanley on Ashok Leyland

Morgan Stanley maintained 'Overweight' rating for Ashok Leyland with a target price of Rs 111 per share. The brokerage said aggressive cost control was at play in Q3. It added that despite a tough demand environment, Ashok Leyland maintained good cost discipline.

Shutterstock.com
CLSA on Astral Poly
2/6

CLSA on Astral Poly

CLSA maintained 'Overperform' rating for Astral Poly with a target price of Rs 1,340 per share. Astral Poly's piping margin was at an all-time high and the brokerage believes that capex expansion should drive the piping volume. Recovery in adhesives is a key for Astral's stock.

Shutterstock.com
Nomura on Dr Reddy’s Labs
3/6

Nomura on Dr Reddy’s Labs

Nomura maintained a 'Buy' rating on Dr Reddy’s stock with a target price of Rs 3,684 per share. DRL to acquire select Wockhardt divisions; the company already has presence in acquired portfolio therapy segments. The brokerage believes the extent of value accretion will depend on stalling declining sales.

Morgan Stanley on Dr. Reddy’s Labs
4/6

Morgan Stanley on Dr. Reddy’s Labs

Morgan Stanley maintained an 'Equal-weight' rating for Dr Reddy with a target price of Rs 3,236 per share. The brokerage says acquisition by DRL demonstrates its intent to strengthen its business. DRL is executing well on its low-risk, high-return strategy with a focus on six select markets.

Shutterstock.com
Goldman Sachs on Info Edge
5/6

Goldman Sachs on Info Edge

Goldman maintained a 'Neutral' rating for InfoEdge with a target price of Rs 2,520 per share. The brokerage believes medium term outlook to remain robust. It forecasts 17% FY20-23 revenue CAGR for the company and marginally cut the revenue estimate.

Shutterstock.com
Credit Suisse on gas stocks
6/6

Credit Suisse on gas stocks

Credit Suisse suggests that gas stocks are likely to have high impact from open access regulations. The brokerage also believes that impact will remain high if current guiding principles are finalised. The probability of immediate risk is low and the market is ignoring the eventuality of low returns of city gas stocks.

Shutterstock.com

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

X
User